You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -4.9% | 3.8% |
ROCE | 46.5% |
Latest | Forecast | |
---|---|---|
P/E | -40.0 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 1.4 | 1.1 |
Price / Book value | 192.4 |
Latest | Forecast | |
---|---|---|
Revenue | 25.0% | -15.8% |
PBT | 0.0% | n/a |
EPS | 0.0% | -274.6% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-12-31 | 5.04 | -3.12 | -12.40p | -2.3 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 6.74 | -0.65 | -1.50p | -44.7 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 10.09 | 0.25 | 1.40p | 90.4 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | 12.61 | -0.62 | -1.30p | -87.7 | 0.0 | n/a | n/a | 0.0% |
Cambridge Cognition forms scientific advisory board Sharecast News | 21 Mar |
---|---|
Cambridge Cognition inks strategic partnership with ActiGraph Sharecast News | 21 Feb |
Cambridge Cognition secures 'significant contract' Sharecast News | 11 Oct |
COG spin-out Monument Therapeutics accesses £1.5m | 23-Apr-24 07:01 |
---|---|
Total Voting Rights and Block Listing Return | 03-Apr-24 00:00 |
Formation of new Scientific Advisory Board | 21-Mar-24 09:13 |
Holding(s) in Company | 21-Feb-24 10:18 |
Cambridge Cognition and ActiGraph Partnership | 21-Feb-24 07:01 |